Archive for the ‘From the Desk of Dr. Karlan’ Category
Beth Y. Karlan, MDNovember 5, 2014
Support from Run for Her forms the foundation of our work at the Cedars-Sinai Women’s Cancer Program. First, Run for Her increases awareness of ovarian cancer in the U.S. and around the world, teaching women (and men) to be alert for symptoms and to see a qualified healthcare provider if they suspect the presence of Read On
Categories: From the Desk of Dr. Karlan
Beth Y. Karlan, MDOctober 17, 2014
In early October we shared a new video series with you featuring Beth Y. Karlan MD. These videos are intended to address your most asked questions about the importance of run for her, as well as the ground breaking research efforts of Dr. Karlan’s team of physicians and scientists. Dr. Karlan first explained why research Read On
Categories: From the Desk of Dr. Karlan
Beth Y. Karlan, MDOctober 1, 2014
Our favorite part of Run for Her is building relationships with ovarian cancer patients, survivors and supporters. Over the past 10 years, we’ve been asked many questions by our supporters. What are the symptoms of ovarian cancer? What are some of the latest research advances in the field of ovarian cancer? How does the Women’s Read On
Categories: From the Desk of Dr. Karlan
Beth Y. Karlan, MDMarch 3, 2014
If you were watching the news or following social media last week, you may have seen this headline: Women with BRCA1 mutations should remove ovaries by age 35. Many major media outlets reported this story, and it is based on study results that appeared in the February 24 issue of the Journal of Clinical Oncology. Read On
Categories: From the Desk of Dr. Karlan, Ovarian Cancer Research
Beth Y. Karlan, MDJune 21, 2013
The Centers for Disease Control and Prevention (CDC) announced this week that the rate of HPV infection among teenage girls has dropped by more than 50% since the introduction of the HPV vaccine. As many of you know, I have been involved with this issue for many years and have been an ardent advocate for Read On
Categories: From the Desk of Dr. Karlan, Ovarian Cancer Research